Antibiotic-resistant bacteria pose a major challenge to healthcare systems worldwide. Due to numerous resistance mechanisms, infections with the pathogen Pseudomonas aeruginosa are particularly feared ...

This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. When Laura Ehrlich gave birth to her ...

Antibiotic resistant bacteria already cause tens of thousands of fatal infections every year, and that number is expected to continue to rise. Even while many commonly used antibiotics are becoming ...

An overview of how specialty laboratories use integrated scientific approaches to deliver high-quality infectious disease ...

We often hold it to be self-evident that antibodies are key to an effective immune response against a pathogen—the more (or more potent) antibodies your body makes, the better it will fight off an ...

Broadly neutralizing antibodies are already being used to fight viruses. This approach could also help to treat infections with multi-resistant bacteria in the future. Antibiotic-resistant bacteria ...

video: This spinning blue shape is the outer shell (glycoprotein) that shields lymphocytic choriomeningitis virus (LCMV) from immune system attack. And yet new research shows that an antibody (grey) ...

Antibodies are immune proteins that our bodies produce to help fight off infection. Where they recognize and bind a pathogen — and how — can give important clues to the microbe’s vulnerabilities. Fred ...

In a recent article published in Immunity, the authors discussed the underlying principles of sterilizing immunity and its importance in protecting individuals against severe acute respiratory ...

Cryo-electron microscopic reconstruction of the antigen binding region of a human antibody (yellow) to the needle tip complex (blue) of the type III secretion system of Pseudomonas aeruginosa.